Clinical trial

A Phase IIb Study of AZD5462 in Patients With Chronic Heart Failure

NCT06299826

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2024-06-04

PhasePHASE2

Study timeline

Study start (actual)2024-06-04Date precision: day

Registry last updated2026-07-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Heart Failureunresolved

Interventions

AZD5462DRUG

PlaceboDRUG

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

SofiaBulgaria3 KrakowPoland2 WroclawPoland2 BratislavaSlovakia2 PlevenBulgaria2 BostonMassachusetts, United States1 PhiladelphiaPennsylvania, United States1 MiamiFlorida, United States1 WarsawPoland1 Chapel HillNorth Carolina, United States1 BuffaloNew York, United States1 LodzPoland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06299826 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.